Related Experiment Videos
Interleukin 7 and estrogen-induced bone loss.
1Department of Pathology and Immunology, Washington University School of Medicine, Barnes-Jewish Hospital, MS 90-31-649, 216 S. Kingshighway, St Louis, MO 63110, USA. rossf@medicine.wustl.edu
Trends in Endocrinology and Metabolism: TEM
|April 26, 2003
Summary
Estrogen regulates cytokines involved in bone turnover. Interleukin 7 (IL-7) and T cells are key factors in postmenopausal osteoporosis, impacting bone-forming and bone-resorbing cells.
Area of Science:
- Endocrinology
- Immunology
- Bone Biology
Background:
- Postmenopausal osteoporosis is a significant health issue linked to increased morbidity and mortality.
- Estrogen's role in regulating bone turnover through cytokine expression is established.
- Tumor necrosis factor alpha (TNF-α) is known to influence bone mass.
Purpose of the Study:
- To elucidate the role of specific cytokines, including interleukin 7 (IL-7), in the pathogenesis of postmenopausal osteoporosis.
- To investigate the contribution of T cells in bone loss associated with gonadal failure.
Main Methods:
- Review of recent studies on cytokine regulation of bone turnover.
- Analysis of the specific actions of IL-7 on osteoblasts and osteoclasts.
- Examination of the role of T cells in postmenopausal bone loss.
Main Results:
- Estrogen regulates cytokines that modulate bone turnover.
- Interleukin 7 (IL-7) suppresses osteoblast activity and stimulates osteoclast formation and function.
- T cells are confirmed as key mediators of bone loss following gonadal failure.
Conclusions:
- Interleukin 7 (IL-7) is implicated in postmenopausal osteoporosis pathogenesis.
- T cells play a critical role in bone loss after menopause.
- Understanding these mechanisms offers potential therapeutic targets for osteoporosis.